Drawing for FIORELLO

USPTO serial 86492414

FIORELLO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SHANOSKI, JOANNA MARIE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FIORELLO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen J Bernstein

Karen J Bernstein Bernstein IP200 Park Avenue, Suite 1700New York, NY 10166UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, autoimmune disorders, arthritis, metabolic disorders, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, anorexia, nausea, loss of appetite, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; analgesic and muscle relaxation pharmaceutical preparations; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative pain, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, autoimmune disorders, arthritis, metabolic disorders, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, anorexia, nausea, loss of appetite, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; medical infusions for muscle relaxation for treating back pain, muscle spasms, spinal and joint strains; extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; food supplements for humans and animals; herbal supplements; herb teas for medicinal purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 3, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 3, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 10, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 9, 2019EX5GSOU EXTENSION 5 GRANTED—
Nov 2, 2018EXT5SOU EXTENSION 5 FILED—
Nov 2, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 5, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 3, 2018EX4GSOU EXTENSION 4 GRANTED—
May 3, 2018EXT4SOU EXTENSION 4 FILED—
May 3, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 27, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 26, 2018EX3GSOU EXTENSION 3 GRANTED—
Jan 26, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 9, 2018DOCKASSIGNED TO EXAMINER—
Jan 2, 2018NREVNOTICE OF REVIVAL - E-MAILED—
Jan 2, 2018TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jan 2, 2018PETGPETITION TO REVIVE-GRANTED—
Jan 2, 2018PROATEAS PETITION TO REVIVE RECEIVED—
Dec 28, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 28, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 4, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 4, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 3, 2017EXT3SOU EXTENSION 3 FILED—
May 5, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 3, 2017EX2GSOU EXTENSION 2 GRANTED—
May 3, 2017EXT2SOU EXTENSION 2 FILED—
May 3, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2016EX1GSOU EXTENSION 1 GRANTED—
Nov 3, 2016EXT1SOU EXTENSION 1 FILED—
Nov 3, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 3, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 8, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 17, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 1, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 26, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 20, 2016ALIEASSIGNED TO LIE—
Jan 7, 2016NREVNOTICE OF REVIVAL - E-MAILED—
Jan 6, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 6, 2016PETGPETITION TO REVIVE-GRANTED—
Jan 6, 2016PROATEAS PETITION TO REVIVE RECEIVED—
Nov 6, 2015MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 6, 2015ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 21, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 10, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2015DOCKASSIGNED TO EXAMINER—
Jan 12, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance